503B Outsourcing

At our 503B Outsourcing Facility, Maitland offers small volume cGMP parenteral products in response to America’s ongoing drug shortages. Our state-of-the-art 14,000 sq. ft. manufacturing facility is US-FDA registered, and our mission is to meet the sterile compounding needs of hospitals and other healthcare providers. We take a no-nonsense approach to getting the job done, and we will provide efficient solutions but never compromise on quality. Our customers include:

  • Hospitals & EMS
  • Clinics
  • Contract Manufacturing
  • Central Fill
  • Pharma

We specialized in the provision of bulk sterile drugs listed on the FDA’s drug shortage list. Our operation has also focused on the provision of non-opioid analgesic options. Contact us for our current list of shortage drugs or special formulation of pharmacopoeial or FDA approved drugs for your office.

Contact us for our current list of shortage drugs or special formulation of pharmacopoeial or FDA approved drugs for your office.

TELL US MORE…

Maitland Labs – Innovative approaches to the development and production of new and existing sterile drugs.